Rivera-Ruiz AP, Villegas-Gómez RM, Mejía-Terrazas GE

Language: Spanish
References: 14
Page: 83-87
PDF size: 236.52 Kb.

ABSTRACT

Background: The transdermal administration of analgesic is a noninvasive method of drug administration. Although the indication for its use is chronic pain, its use in post-operative acute pain can be a good option reason why the objective of this study was to evaluate the effectiveness of specific doses in abdominal hysterectomy, as well as the potential adverse effects. Material and methods: Controlled Clinical Trial Administer transdermal buprenorphine of 10 mg, 15 mg and 20 mg, compared with placebo. The intensity of the pain to 30 min, 60 min, 90 min, 120 min, 4 hours, 8 hours, 12 hours, 16 hours, 20 hours and 24 hours, in rest and to the movement was evaluated. Statistic analysis: Chi square (χ²) was used for qualitative variables, an analysis of variance (ANOVA) to compare the groups as well as post hoc tests by the Turkey method, statistical significance was considered if p ‹ 0.05. Results: The mean of pain in movement in group 1 was 2.07 ± 1.08 for group 1.5 from 2.0 ± 1 for group 2 of 1.87 ± 1.02, for group P it was 3.3 ± 1.98 The VAS at rest for all groups was 1.0 ± 0; except for the control that was 2.8 ± 1.02. Adverse reactions were in group 1 of 53.6% nausea in 11.25%, drowsiness in 42.35%. Group 1.5 67.73% presented, being only drowsiness the event found. For group 2, 82.79% presented adverse events, of these 5.42% presented nausea and 77.37% somnolence. Conclusion: It is an effective and safe alternative for the management of the post-operative pain.

REFERENCES

1. López-Guzmán J, Pazos-Alvarado RE, Moyao-García D, Galicia-Núñez A. Prevalencia e incidencia del dolor en los pacientes hospitalizados en el Hospital Infantil de México «Federico Gómez» en un período de seis meses. Rev Mex Anest. 2013;36:93-97.

2. Sada-Ovalle T, Delgado-Hernández E, Castellanos-Olivares A. Prevalencia del dolor postoperatorio en cirugía electiva de pacientes del hospital de especialidades del Centro Médico Nacional Siglo XXI IMSS. Rev Soc Esp Dolor. 2011;2:91-97.

3. Wang ZQ, Zhan SY, Fransen M, Lin JH. Clinical attitudes towards pain treatment post-orthopedic surgery: a multicenter study in Beijing. Chin Med J (Engl). 2012;125:2499-2504.

4. Pergolizzi JV, Taylor R, Plancarte R, Bashkansky D, Muñiz E. ¿Es la buprenorfina una buena opción en el manejo de dolor postoperatorio? Rev Soc Esp Dolor. 2012;19:281-292.

5. Heit HA, Gourlay DL. Buprenorphine: new tricks with an old molecule for pain management. Clin J Pain. 2008;24:93-97.

6. Privitera C, Guzzetta G, Ferarotto V, Bambiona S. Postoperative pain management in shoulder surgery with transdermal buprenorphine patches. Reg Anesth Pain Med. 2008;33:184.

7. Privitera C, Guzzetta G, Ferrarotto E, Bambino S. Transdermal buprenorphine patches for postoperative pain management in orthopaedic surgery in the elderly. Reg Anesth Pain Med. 2008;33:187.

8. Cerruela G, Fernandez A, Baez ME. Eficacia del parche transdermico de buprenorfina en el tratamiento del dolor postoperatorio. [Internet] Cartel presentado en VIII congreso centroamericano y del Caribe de anestesiologia y reanimacion 21 al 24 de octubre 2008 La Habana Cuba. Disponible en: http://www.fesacac2008.sld.cu/Members/gcerruela/eficacia-del-parche-transdermico-de-buprenorfina-en-el-tratamiento-del-dolor-postoperatorio/

9. Setti T, Sanfilippo F, Leykin Y. Transdermal buprenorphine for postoperative pain control in gynecological surgery: a prospective randomized study. Curr Med Res Opin. 2012;28:1597-1608.

10. Goicoechea C, Martín MI. Buprenorfina en el dolor postoperatorio. Rev Soc Esp Dolor. 2012;19:279-280.

11. Böhme K. Buprenorphine in a transdermal therapeutic system a new option. Clin Rheumatol. 2002;21:s13-16.

12. Evans HC, Easthope SE. Transdermal buprenorphine. Drugs. 2003;63:1999-2010.

13. Ekstein MP, Weinbroum AA. Immediate Postoperative pain in orthopedic patients is more intense and requires more analgesia than in post-laparotomy patients. Pain Med. 2011;12:308-313.

14. Vander K, Parera E, Jacobs C, Dewulf V, Baeck M, Pujol RM, et al. Allergic contact dermatitis from transdermal buprenorphine. Contact Dermatitis. 2008;59:366-369.